USANA Health Sciences EBITDA Margin 2012-2026 | USNA

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for USANA Health Sciences (USNA) over the last 10 years. The current EBITDA margin for USANA Health Sciences as of June 30, 2026 is .
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
USANA Health Sciences EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2026-06-30 $0.91B $0.07B 7.34%
2026-03-31 $0.93B $0.08B 8.10%
2025-12-31 $0.93B $0.08B 8.32%
2025-09-30 $0.91B $0.08B 8.42%
2025-06-30 $0.90B $0.09B 9.67%
2025-03-31 $0.88B $0.09B 9.69%
2024-12-31 $0.86B $0.09B 10.41%
2024-09-30 $0.86B $0.10B 12.06%
2024-06-30 $0.88B $0.11B 12.11%
2024-03-31 $0.90B $0.11B 12.44%
2023-12-31 $0.92B $0.11B 12.39%
2023-09-30 $0.93B $0.11B 12.19%
2023-06-30 $0.95B $0.12B 12.46%
2023-03-31 $0.97B $0.12B 12.54%
2022-12-31 $1.00B $0.13B 12.93%
2022-09-30 $1.04B $0.14B 13.31%
2022-06-30 $1.08B $0.16B 14.47%
2022-03-31 $1.15B $0.18B 15.73%
2021-12-31 $1.19B $0.19B 16.19%
2021-09-30 $1.23B $0.21B 17.32%
2021-06-30 $1.26B $0.22B 17.37%
2021-03-31 $1.18B $0.20B 17.33%
2020-12-31 $1.14B $0.20B 17.52%
2020-09-30 $1.10B $0.19B 17.43%
2020-06-30 $1.06B $0.18B 17.11%
2020-03-31 $1.06B $0.17B 16.40%
2019-12-31 $1.06B $0.17B 15.93%
2019-09-30 $1.09B $0.17B 15.79%
2019-06-30 $1.13B $0.18B 16.09%
2019-03-31 $1.17B $0.20B 17.01%
2018-12-31 $1.19B $0.21B 17.33%
2018-09-30 $1.16B $0.19B 16.60%
2018-06-30 $1.13B $0.18B 15.78%
2018-03-31 $1.08B $0.16B 14.76%
2017-12-31 $1.05B $0.15B 14.14%
2017-09-30 $1.03B $0.14B 13.92%
2017-06-30 $1.02B $0.15B 14.43%
2017-03-31 $1.02B $0.15B 14.79%
2016-12-31 $1.01B $0.15B 15.11%
2016-09-30 $0.99B $0.16B 15.72%
2016-06-30 $0.97B $0.16B 16.27%
2016-03-31 $0.94B $0.16B 16.72%
2015-12-31 $0.92B $0.15B 16.56%
2015-09-30 $0.91B $0.15B 16.32%
2015-06-30 $0.87B $0.14B 16.06%
2015-03-31 $0.83B $0.13B 15.72%
2014-12-31 $0.79B $0.13B 15.82%
2014-09-30 $0.75B $0.12B 16.18%
2014-06-30 $0.73B $0.12B 15.89%
2014-03-31 $0.73B $0.12B 16.96%
2013-12-31 $0.72B $0.13B 17.55%
2013-09-30 $0.70B $0.13B 17.83%
2013-06-30 $0.69B $0.12B 17.92%
2013-03-31 $0.66B $0.11B 16.87%
2012-12-31 $0.65B $0.11B 16.33%
2012-09-30 $0.63B $0.10B 15.65%
2012-06-30 $0.61B $0.09B 15.37%
2012-03-31 $0.59B $0.09B 15.01%
2011-12-31 $0.58B $0.09B 14.58%
2011-09-30 $0.58B $0.08B 14.43%
2011-06-30 $0.57B $0.08B 14.66%
2011-03-31 $0.54B $0.08B 14.55%
2010-12-31 $0.52B $0.08B 14.67%
2010-09-30 $0.50B $0.07B 14.69%
2010-06-30 $0.47B $0.07B 13.95%
2010-03-31 $0.46B $0.06B 13.51%
2009-12-31 $0.44B $0.06B 13.27%
2009-09-30 $0.43B $0.05B 11.60%
2009-06-30 $0.43B $0.05B 11.71%
2009-03-31 $0.42B $0.05B 12.50%
2008-12-31 $0.43B $0.05B 12.59%
2008-09-30 $0.43B $0.06B 14.99%
2008-06-30 $0.43B $0.07B 15.96%
2008-03-31 $0.43B $0.07B 16.47%
2007-12-31 $0.42B $0.08B 17.92%
2007-09-30 $0.41B $0.08B 18.29%
2007-06-30 $0.40B $0.07B 18.69%
2007-03-31 $0.38B $0.07B 18.78%
2006-12-31 $0.37B $0.07B 18.63%
2006-09-30 $0.34B $0.07B 20.06%
2006-06-30 $0.33B $0.07B 20.36%
2006-03-31 $0.33B $0.07B 20.55%
2005-12-31 $0.32B $0.07B 20.95%
2005-09-30 $0.31B $0.06B 19.49%
2005-06-30 $0.30B $0.06B 19.33%
2005-03-31 $0.29B $0.05B 18.95%
2004-12-31 $0.27B $0.05B 18.15%
2004-09-30 $0.26B $0.05B 17.90%
2004-06-30 $0.24B $0.04B 17.84%
2004-03-31 $0.22B $0.04B 17.65%
2003-12-31 $0.20B $0.04B 18.00%
2003-09-30 $0.18B $0.03B 17.32%
2003-06-30 $0.16B $0.03B 16.15%
2003-03-31 $0.15B $0.02B 15.07%
2002-12-31 $0.13B $0.02B 13.43%
2002-09-30 $0.13B $0.01B 11.20%
2002-06-30 $0.12B $0.01B 9.24%
2002-03-31 $0.12B $0.01B 7.76%
2001-12-31 $0.12B $0.01B 6.96%
2001-09-30 $0.11B $0.05B 42.98%
2001-06-30 $0.12B $0.05B 42.61%
2001-03-31 $0.12B $0.05B 41.88%
2000-12-31 $0.12B $0.05B 42.15%
2000-09-30 $0.13B $0.07B 55.56%
2000-06-30 $0.13B $0.07B 56.25%
2000-03-31 $0.13B $0.08B 58.14%
1999-12-31 $0.13B $0.08B 59.38%
1999-09-30 $0.13B $0.02B 14.96%
1999-06-30 $0.13B $0.02B 15.75%
1999-03-31 $0.13B $0.02B 15.87%
1998-12-31 $0.12B $0.02B 15.70%
1998-09-30 $0.11B $0.04B 33.63%
1998-06-30 $0.10B $0.05B 49.04%
1998-03-31 $0.09B $0.06B 67.02%
1997-12-31 $0.09B $0.07B 84.88%
1997-09-30 $0.08B $0.06B 79.49%
1997-06-30 $0.07B $0.05B 75.00%
1997-03-31 $0.06B $0.05B 73.77%
1996-12-31 $0.05B $0.04B 74.07%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.275B $0.925B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.396B 22.59
Takeda Pharmaceutical (TAK) Japan $59.919B 11.13
UCB SA (UCBJY) Belgium $45.739B 0.00
Otsuka Holdings, - (OTSKY) Japan $39.680B 14.84
BeOne Medicines - (ONC) Switzerland $38.041B 61.00
Sandoz Group AG (SDZNY) Switzerland $35.464B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.072B 21.27
Zoetis (ZTS) United States $30.343B 11.16
Astellas Pharma (ALPMY) Japan $26.892B 8.90
United Therapeutics (UTHR) United States $21.460B 17.90
Merck (MKKGY) Germany $19.487B 15.54
Shionogi (SGIOY) Japan $15.947B 9.37
IPSEN (IPSEY) France $15.395B 0.00
Neurocrine Biosciences (NBIX) United States $15.249B 20.72
Summit Therapeutics (SMMT) United States $13.881B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.089B 0.00
Corcept Therapeutics (CORT) United States $11.979B 263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Eisai (ESAIY) $8.924B 0.00
Ionis Pharmaceuticals (IONS) United States $7.852B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.523B 32.64
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.105B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.317B 19.36
Grifols, S.A (GRFS) Spain $5.009B 0.00
Definium Therapeutics (DFTX) United States $4.947B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.157B 0.00
Indivior Pharmaceuticals (INDV) United States $4.039B 9.38
Enliven Therapeutics (ELVN) United States $3.910B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.694B 0.00
Dyne Therapeutics (DYN) United States $3.343B 0.00
Hypermarcas (HYPMY) Brazil $3.203B 9.10
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.529B 0.00
Guardian Pharmacy Services (GRDN) United States $2.390B 45.28
Nektar Therapeutics (NKTR) United States $2.275B 0.00
Ocular Therapeutix (OCUL) United States $2.238B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.146B 15.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.085B 5.63
Xencor (XNCR) United States $1.766B 0.00
KARDIGAN INC (KARD) United States $1.735B 0.00
Xeris Biopharma Holdings (XERS) United States $1.366B 107.00
Harrow (HROW) United States $1.269B 0.00
Seaport Therapeutics (SPTX) United States $1.229B 0.00
Aktis Oncology (AKTS) United States $1.204B 0.00
Cronos Group (CRON) Canada $1.179B 29.09
Bioventus (BVS) United States $1.093B 17.10
Savara (SVRA) United States $1.081B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.885B 0.00
Avalo Therapeutics (AVTX) United States $0.862B 0.00
Ardelyx (ARDX) United States $0.847B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.821B 11.32
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.773B 0.00
Achieve Life Sciences (ACHV) Canada $0.753B 0.00
4D Molecular Therapeutics (FDMT) United States $0.753B 0.00
Silence Therapeutics (SLN) United Kingdom $0.750B 0.00
Apnimed (APMD) $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.711B 3.13
Zevra Therapeutics (ZVRA) United States $0.692B 7.37
Ironwood Pharmaceuticals (IRWD) United States $0.671B 5.21
OmniAb (OABI) United States $0.630B 0.00
Altimmune (ALT) United States $0.628B 0.00
Aquestive Therapeutics (AQST) United States $0.604B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.526B 0.00
Indaptus Therapeutics (INDP) United States $0.485B 0.00
Relmada Therapeutics (RLMD) United States $0.474B 0.00
ARS Pharmaceuticals (SPRY) United States $0.423B 0.00
Larimar Therapeutics (LRMR) United States $0.406B 0.00
Prelude Therapeutics (PRLD) United States $0.361B 0.00
Century Therapeutics (IPSC) United States $0.359B 0.00
Lexeo Therapeutics (LXEO) United States $0.339B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.314B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
Elite Pharmaceuticals (ELTP) United States $0.268B 12.44
Lyell Immunopharma (LYEL) United States $0.267B 0.00
Akebia Therapeutics (AKBA) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Nature's Sunshine Products (NATR) United States $0.230B 11.17
AleAnna (ANNA) United States $0.226B 17.84
Protara Therapeutics (TARA) United States $0.222B 0.00
Cardiol Therapeutics (CRDL) Canada $0.215B 0.00
Siga Technologies (SIGA) United States $0.214B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Korro Bio (KRRO) United States $0.207B 0.00
Surrozen (SRZN) United States $0.206B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Organogenesis (ORGO) United States $0.188B 0.00
Minerva Neurosciences (NERV) United States $0.183B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Atrium Therapeutics (RNA) United States $0.173B 0.00
NRx Pharmaceuticals (NRXP) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.131B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
VAXART, INC (VXRT) United States $0.117B 3.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Rafael Holdings (RFL) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.111B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
PolyPid (PYPD) Israel $0.098B 0.00
HST Global (HSTC) United States $0.092B 0.00
ElectroCore (ECOR) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.083B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Telomir Pharmaceuticals (TELO) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Acrivon Therapeutics (ACRV) United States $0.078B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.053B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Context Therapeutics (CNTX) United States $0.033B 0.00
Optimi Health (OPTH) Canada $0.029B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.027B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Enlivex (ENLV) Israel $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00